Skip to main content

What the FDA labels say about taking them together

Cisplatin and gadobenate

Gadobenate's FDA label of March 16, 2025 names cisplatin in its drug interactions section; the cisplatin label PlainMeds reads does not name gadobenate. The gadobenate label: “Therefore MultiHance may prolong the systemic exposure of drugs such as cisplatin, anthracyclines, vinca alkaloids (e.g. vincristine), methotrexate, etoposide, tamoxifen, and paclitaxel.”

Check it at the source: the cisplatin FDA label on DailyMed (effective September 16, 2021, WG Critical Care, LLC); the gadobenate FDA label on DailyMed (effective March 16, 2025, BRACCO DIAGNOSTICS INC).

What does the cisplatin label say about gadobenate?

Cisplatin's label (effective September 16, 2021) does not name gadobenate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (CISplatin), NDA018057 (Hq Spclt Pharma), as published by WG Critical Care, LLC, effective September 16, 2021 (SPL set 2bf8d2fb-80c8-401d-8e9b-d58463f5e954), via openFDA; the full label on DailyMed

What does the gadobenate label say about cisplatin?

Gadobenate label, drug interactions

Therefore MultiHance may prolong the systemic exposure of drugs such as cisplatin, anthracyclines (e.g. doxorubicin, daunorubicin), vinca alkaloids (e.g. vincristine), methotrexate, etoposide, tamoxifen, and paclitaxel.

Source: FDA drug label (MultiHance), BRACCO DIAGNOSTICS INC, effective March 16, 2025 (SPL set f63abe56-46d9-4e32-afb1-f4e22370717d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

9Cisplatin generic labelers
0Gadobenate generic labelers
CisplatinGadobenate
Labeled forn/an/a
Boxed warningYesYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?